Matteo G Carrabba - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Matteo G Carrabba

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Blood Advances|March 6, 2025

Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AMLGiovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, et al.

Nature Medicine|June 1, 2026

Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trialBernhard Gentner, Marica Eoli, Francesca Farina, et al.

Blood|June 10, 2023

Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendationsKai Rejeski, Marion Subklewe, Mahmoud Aljurf, et al.

Nature Medicine|March 27, 2019

Immune signature drives leukemia escape and relapse after hematopoietic cell transplantationCristina Toffalori, Laura Zito, Valentina Gambacorta, et al.

Pageof 3

Search research articles

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Blood Advances|March 6, 2025

Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AMLGiovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, et al.

Nature Medicine|June 1, 2026

Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trialBernhard Gentner, Marica Eoli, Francesca Farina, et al.

Blood|June 10, 2023

Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendationsKai Rejeski, Marion Subklewe, Mahmoud Aljurf, et al.

Nature Medicine|March 27, 2019

Immune signature drives leukemia escape and relapse after hematopoietic cell transplantationCristina Toffalori, Laura Zito, Valentina Gambacorta, et al.

Pageof 3